PNBK · Patriot National Bancorp Inc

On July 29, 2026, the Reporting Person was granted RSUs equal to 88,494 shares of Common Stock of the Issuer, which will vest over three years (29,498 shares, 29,499 shares, and 29,499 shares respectively as of July 1, 2027, 2028 and 2029).

On July 29, 2026, the Reporting Person was granted RSUs equal to 88,496 shares of Common Stock of the Issuer, which will vest over three years (29,498 shares, 29,499 shares, and 29,499 shares respectively as of July 1, 2027, 2028 and 2029).

On July 29, 2026, the Reporting Person was granted RSUs equal to 88,496 shares of Common Stock of the Issuer, which will vest over three years (29,498 shares, 29,499 shares, and 29,499 shares respectively as of July 1, 2027, 2028 and 2029).

On July 29, 2026, the Reporting Person was granted RSUs equal to 66,372 shares of Common Stock of the Issuer, which will vest over three years (22,124 shares, 22,124 shares, and 22,124 shares respectively as of July 1, 2027, 2028 and 2029).

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 400,000 shares of Common Stock of the Issuer, which will vest over three years (133,333 shares, 133,333 shares, and 133,334 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 133,333 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over three years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 22,222 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over three years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 22,222 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2026, upon the expiration of the restricted period on 552,927 restricted stock units ("RSUs") granted to the reporting person pursuant to an award agreement effective July 1, 2025 (previously disclosed in a Form 4 filed on August 14, 2025), 552,927 RSUS settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over three years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 22,222 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over three years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 22,222 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On November 19, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 37,727 shares of Common Stock of the Issuer, which will vest over three years (12,575 shares, 12,575 shares, and 12,576 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 12,575 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over three years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 22,222 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over three years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 22,222 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

Represents 303,861 shares of Common Stock withheld by the Issuer upon settlement of the RSUs to satisfy the Reporting Person's applicable tax withholding obligations. The shares were withheld at a price of $1.20 per share, representing the closing price of the Issuer's Common Stock on July 1, 2026. The withheld shares were not delivered to the Reporting Person.

On November 19, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 37,727 shares of Common Stock of the Issuer, which will vest over three years (12,575 shares, 12,575 shares, and 12,576 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 12,575 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 400,000 shares of Common Stock of the Issuer, which will vest over three years (133,333 shares, 133,333 shares, and 133,334 shares respectively as of July 1, 2026, 2027 and 2028). On July 1, 2026, the first installment of 133,333 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On July 1, 2026, upon the expiration of the restricted period on 552,927 restricted stock units ("RSUs") granted to the reporting person pursuant to an award agreement effective July 1, 2025 (previously disclosed in a Form 4 filed on August 14, 2025), 552,927 RSUS settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On May 27, 2026, the Reporting Person purchased 85,000 shares of the Issuer's common stock on the open market at an average price of $0.96 per share.

N/A

On May 20, 2026, pursuant to the Reporting Person's employment agreement with the Issuer dated April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 74,983 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date (24,994 shares, 24,994 shares, and 24,995 shares respectively as of May 20, 2027, 2028 and 2029).

N/A

On May 20, 2026, pursuant to the Reporting Person's employment agreement with the Issuer dated April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 74,983 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date (24,994 shares, 24,994 shares, and 24,995 shares respectively as of May 20, 2027, 2028 and 2029).

N/A

On May 20, 2026, pursuant to the Reporting Person's employment agreement with the Issuer, effective as of March 20, 2025 (the "Employment Agreement"), the Reporting Person was granted Restricted Stock Units ("RSUs") equal to: (i) 575 shares of Common Stock as a quarterly equity award for Q4 2025, and (ii) 104,452 shares of Common Stock as a quarterly equity award for Q1 2026 (collectively, the "May 2026 RSU Grants"). Each of the May 2026 RSU Grants will vest in twelve (12) equal monthly installments commencing on May 20, 2026 and ending on May 20, 2027. Pursuant to the terms of the Employment Agreement, the May 2026 RSU Grants are subject to a one-year restricted period expiring on May 20, 2027 and will be settled on the date of expiration of the restricted period.

On May 20, 2026, the Reporting Person purchased 87,719 shares of the Issuer's common stock on the open market at an average price of $1.15 per share.

N/A

On May 20, 2026, pursuant to the Reporting Person's employment agreement with the Issuer, effective as of March 20, 2025 (the "Employment Agreement"), the Reporting Person was granted Restricted Stock Units ("RSUs") equal to: (i) 575 shares of Common Stock as a quarterly equity award for Q4 2025, and (ii) 104,452 shares of Common Stock as a quarterly equity award for Q1 2026 (collectively, the "May 2026 RSU Grants"). Each of the May 2026 RSU Grants will vest in twelve (12) equal monthly installments commencing on May 20, 2026 and ending on May 20, 2027. Pursuant to the terms of the Employment Agreement, the May 2026 RSU Grants are subject to a one-year restricted period expiring on May 20, 2027 and will be settled on the date of expiration of the restricted period.

Represents 121,776 shares of Common Stock withheld by the Issuer upon settlement of the RSUs to satisfy the Reporting Person's applicable tax withholding obligations. The shares were withheld at a price of $1.23 per share, representing the closing price of the Issuer's Common Stock on April 30, 2026. The withheld shares were not delivered to the Reporting Person.

Represents 56,718 shares of Common Stock withheld by the Issuer upon settlement of the RSUs to satisfy the Reporting Person's applicable tax withholding obligations. The shares were withheld at a price of $1.23 per share, representing the closing price of the Issuer's Common Stock on April 30, 2026. The withheld shares were not delivered to the Reporting Person.

On August 7, 2025, pursuant to an award agreement effective as of April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 450,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date. On April 30, 2026, the first installment of 150,000 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 1,000,000 shares of Common Stock of the Issuer, which will vest over three years (333,333 shares, 333,333 shares, and 333,334 shares respectively as of April 30, 2026, 2027 and 2028). On April 30, 2026, the first installment of 333,333 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 1,000,000 shares of Common Stock of the Issuer, which will vest over three years (333,333 shares, 333,333 shares, and 333,334 shares respectively as of April 30, 2026, 2027 and 2028). On April 30, 2026, the first installment of 333,333 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On August 13, 2025, pursuant to an award agreement effective as of April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 1,000,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date. On April 30, 2026, the first installment of 333,333 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On August 7, 2025, pursuant to an award agreement effective as of April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 450,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date. On April 30, 2026, the first installment of 150,000 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

On August 13, 2025, pursuant to an award agreement effective as of April 30, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 1,000,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date. On April 30, 2026, the first installment of 333,333 RSUs vested and settled and the Issuer delivered shares of Common Stock in settlement thereof. No consideration was paid by the Reporting Person in connection with the settlement.

Represents 123,683 shares of Common Stock withheld by the Issuer upon settlement of the RSUs to satisfy the Reporting Person's applicable tax withholding obligations. The shares were withheld at a price of $1.23 per share, representing the closing price of the Issuer's Common Stock on April 30, 2026. The withheld shares were not delivered to the Reporting Person.

On March 25, 2026, upon the expiration of the restricted period on 4,049,593 restricted stock units ("RSUs") granted to the reporting person on March 20, 2025 (previously disclosed in a Form 4 filed on April 1, 2025), 2,089,043 shares of the issuer's common stock were delivered to the reporting person, with 1,960,550 shares withheld to cover the reporting person's tax obligations in connection with the vesting of the RSUs in accordance with the issuer's tax withholding policy and applicable tax withholding requirements.

On March 25, 2026, upon the expiration of the restricted period on 4,049,593 restricted stock units ("RSUs") granted to the reporting person on March 20, 2025 (previously disclosed in a Form 4 filed on April 1, 2025), 2,089,043 shares of the issuer's common stock were delivered to the reporting person, with 1,960,550 shares withheld to cover the reporting person's tax obligations in connection with the vesting of the RSUs in accordance with the issuer's tax withholding policy and applicable tax withholding requirements.

On March 3, 2026, the Reporting Person purchased 400 shares of the Issuer's common stock on the open market at an average price of $1.32 per share.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

Represents the conversion of 2,000,000 shares of Patriot National Bancorp, Inc.'s (the "Issuer") non-voting common stock into 2,000,000 shares of the Issuer's voting common stock pursuant to the Issuer's Amended and Restated Certificate of Incorporation. No consideration was paid in connection with the conversion.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

Represents the conversion of 2,000,000 shares of Patriot National Bancorp, Inc.'s (the "Issuer") non-voting common stock into 2,000,000 shares of the Issuer's voting common stock pursuant to the Issuer's Amended and Restated Certificate of Incorporation. No consideration was paid in connection with the conversion.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

On August 19, 2025, the Reporting Person purchased 500 shares of the Issuer's common stock on the open market at an average price of $1.59 per share.

On August 13, 2025, the Reporting Person received an award agreement effective as of April 30, 2025 granting Restricted Stock Units equal to 1,000,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date.

On August 13, 2025, the Reporting Person received an award agreement effective July 1, 2025 for Restricted Stock Units (RSUs) equal to 552,927 shares of Common Stock, par value $0.01 per share of Patriot National Bancorp, Inc. (the Issuer). The RSUs were granted pursuant to an Employment Agreement between the Reporting Person and the Issuer, effective as of March 20, 2025. The RSUs vest in 12 equal monthly installments commencing on July 1, 2025 and ending on July 1, 2026. Vested RSUs represent the right to be settled on July 1, 2026.

On August 7, 2025, the Reporting Person received an award agreement effective as of April 30, 2025 granting Restricted Stock Units equal to 450,000 shares of Common Stock, which will vest in three equal installments on each of the first three anniversaries of the award date.

On July 24, 2025, the Reporting Person purchased 175 shares of the Issuer's common stock on the open market at an average price of $1.55 per share.

On July 17, 2025, the Reporting Person purchased 375 shares of the Issuer's common stock on the open market at an average price of $1.44 per share.

On March 20, 2025, Patriot National Bancorp, Inc. (the Issuer) completed its private placement of: (i) shares of Common Stock, par value $0.01 per share of the Issuer (the Voting Common Stock) at a purchase price of $0.75 per share, and (ii) shares of a new series of the Issuer's preferred stock, no par value per share (the Series A Preferred Stock), with a liquidation preference of $60 per share (the Private Placement). Steven and Ainslie Sugarman Living Trust (the Trust) purchased, as part of the Private Placement, 19,167 shares of Series A Preferred Stock, convertible into 1,533,333 shares of Voting Common Stock, subject to the limitation that no investor in the Private Placement has the right to become the beneficial owner (as determined under Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act)) of more than 9.99% of the issued and outstanding voting securities of the Issuer.

On July 3, 2025, all issued and outstanding shares of Series A Preferred Stock automatically converted into shares of non-voting common stock, par value $0.01 per share ("Non-Voting Common Stock"), of the Issuer, pursuant to the terms of the Amended and Restated Certificate of Incorporation of the Issuer. Series A Preferred Stock had no expiration date. Each share of Non-Voting Common Stock is convertible into one share of Voting Common Stock, subject to the terms of the Amended and Restated Certificate of Incorporation of the Issuer, including the limitation that no holder of Non-Voting Common Stock has the right to become the beneficial owner (as determined under Rule 13d-3 under the Exchange Act) of more than 9.99% of the issued and outstanding voting securities of the Issuer. Voting Common Stock has no expiration date.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

On July 3, 2025, all issued and outstanding shares of Series A Preferred Stock automatically converted into shares of non-voting common stock, par value $0.01 per share ("Non-Voting Common Stock"), of the Issuer, pursuant to the terms of the Amended and Restated Certificate of Incorporation of the Issuer. Series A Preferred Stock had no expiration date. Each share of Non-Voting Common Stock is convertible into one share of Voting Common Stock, subject to the terms of the Amended and Restated Certificate of Incorporation of the Issuer, including the limitation that no holder of Non-Voting Common Stock has the right to become the beneficial owner (as determined under Rule 13d-3 under the Exchange Act) of more than 9.99% of the issued and outstanding voting securities of the Issuer. Voting Common Stock has no expiration date.

The Trust was also issued 5,833 shares of Series A Preferred Stock, convertible into 466,667 shares of Common Stock, as a reimbursement of the Reporting Person's legal fees and expenses relating to the Private Placement, subject to the limitation that the Reporting Person does not have the right to become, directly or indirectly, the beneficial owner of more than 9.99% of the issued and outstanding voting securities of the Issuer.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

On March 20, 2025, Patriot National Bancorp, Inc. (the Issuer) completed its private placement of: (i) shares of Common Stock, par value $0.01 per share of the Issuer (the Voting Common Stock) at a purchase price of $0.75 per share, and (ii) shares of a new series of the Issuer's preferred stock, no par value per share (the Series A Preferred Stock), with a liquidation preference of $60 per share (the Private Placement). Steven and Ainslie Sugarman Living Trust (the Trust) purchased, as part of the Private Placement, 19,167 shares of Series A Preferred Stock, convertible into 1,533,333 shares of Voting Common Stock, subject to the limitation that no investor in the Private Placement has the right to become the beneficial owner (as determined under Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act)) of more than 9.99% of the issued and outstanding voting securities of the Issuer.

On July 3, 2025, all issued and outstanding shares of Series A Preferred Stock automatically converted into shares of non-voting common stock, par value $0.01 per share ("Non-Voting Common Stock"), of the Issuer, pursuant to the terms of the Amended and Restated Certificate of Incorporation of the Issuer. Series A Preferred Stock had no expiration date. Each share of Non-Voting Common Stock is convertible into one share of Voting Common Stock, subject to the terms of the Amended and Restated Certificate of Incorporation of the Issuer, including the limitation that no holder of Non-Voting Common Stock has the right to become the beneficial owner (as determined under Rule 13d-3 under the Exchange Act) of more than 9.99% of the issued and outstanding voting securities of the Issuer. Voting Common Stock has no expiration date.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

On July 3, 2025, all issued and outstanding shares of Series A Preferred Stock automatically converted into shares of non-voting common stock, par value $0.01 per share ("Non-Voting Common Stock"), of the Issuer, pursuant to the terms of the Amended and Restated Certificate of Incorporation of the Issuer. Series A Preferred Stock had no expiration date. Each share of Non-Voting Common Stock is convertible into one share of Voting Common Stock, subject to the terms of the Amended and Restated Certificate of Incorporation of the Issuer, including the limitation that no holder of Non-Voting Common Stock has the right to become the beneficial owner (as determined under Rule 13d-3 under the Exchange Act) of more than 9.99% of the issued and outstanding voting securities of the Issuer. Voting Common Stock has no expiration date.

The Trust was also issued 5,833 shares of Series A Preferred Stock, convertible into 466,667 shares of Common Stock, as a reimbursement of the Reporting Person's legal fees and expenses relating to the Private Placement, subject to the limitation that the Reporting Person does not have the right to become, directly or indirectly, the beneficial owner of more than 9.99% of the issued and outstanding voting securities of the Issuer.

The Trust is a revocable living trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are the trustees of the Trust.

On July 1, 2025, the Reporting Person was granted Restricted Stock Units ("RSUs") equal to 66,667 shares of Common Stock of the Issuer, which will vest over 3 years (22,222 shares, 22,222 shares, and 22,223 shares respectively as of July 1, 2026, 2027 and 2028).